Clinical Trials
All Clinical Trials - Page 9 of 52
A complete, crawlable index of every tracked clinical trial of peptide compounds. Use the search browser at /trials for filtering, or page through the full list here.
- NCT07638592N/ACompleted
Tirzepatide-Based Prehabilitation Before Elective Ventral and Incisional Hernia Repair in Patients With Obesity
Tirzepatide
- NCT06918405Phase 3Active Not Recruiting
Efficacy and Safety of Tirzepatide for Weight Management
Tirzepatide
- NCT07281196N/ACompleted
Semaglutide Effects on Sleep Apnea in Patients With Type 2 Diabetes/Obesity and Comorbid Obstructive Sleep Apnea
Semaglutide
- NCT06792422Phase 4Recruiting
A Study Investigating Oral Semaglutide in People with Open-Angle Glaucoma
Semaglutide
- NCT06764056N/ANot Yet Recruiting
Characterization and Management of Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)
Semaglutide
- NCT06670053N/ARecruiting
Puberty, Testosterone, and Brain Development
Gonadorelin
- NCT07325435Phase 4Active Not Recruiting
Beta Cell Function in Type 2 Diabetes: Differential Effects of SGLT2 Inhibitors and GLIP-Receptor Agonists
Semaglutide
- NCT05670379Phase 1Completed
Assessment of Safety, Tolerability and Drug Levels of Exenatide Implant
Semaglutide
- NCT06751589EARLY_Phase 1Recruiting
A Study of a Weight Loss Intervention in People With Endometrial Cancer
Tirzepatide
- NCT06305598Phase 1Recruiting
Bipolar Androgen Therapy to Restore Sensitivity to Androgen Deprivation Therapy for Patients With Metastatic Castration Resistant Prostate Cancer
Gonadorelin
- NCT07303556N/AActive Not Recruiting
Improving Cardiovascular Disease Diagnosis and Treatment in Kazakhstan Using Metabolic Correction With GLP-1 Drugs
Tirzepatide
- NCT07092618Phase 2/Phase 3Recruiting
Effectiveness of Alternative Therapies in Maintaining Weight Loss Achieved by GLP-1 Medications Post-Cessation
Semaglutide
- NCT06692348Phase 1Completed
A Study of Orforglipron (LY3502970) to Compare a Single Capsule and Multiple Capsules in Healthy Participants
Orforglipron
- NCT06704763Phase 1Completed
A Drug-Drug Interaction Study of Orforglipron (LY3502970) With Quinidine in Healthy Participants
Orforglipron
- NCT06382948Phase 3Recruiting
Elacestrant + Everolimus in Patients ER+/HER2-, ESR1mut, Advanced Breast Cancer Progressing to ET and CDK4/6i.
Gonadorelin
- NCT06648031Phase 1Completed
Comparison of the Safety, Efficacy and Pharmacokinetics of DehydraTECH -CBD and DehydraTECH-GLP1 Agonists Alone or in Combination, in Overweight or Obese, Pre- and Type 2 Diabetic Participants
Tirzepatide
- NCT06700538Phase 1/Phase 2Recruiting
A First-In-Human Study of ARO-INHBE in Adults With Obesity With and Without Type 2 Diabetes Mellitus
Tirzepatide
- NCT06683066Phase 1Recruiting
Study on Human Bioequivalence of Triprerelin Acetate for Injection
Gonadorelin
- NCT06719011Phase 1Recruiting
A Study on How NNC0174-1213 Works in People With Overweight or Obesity.
Cagrilintide
- NCT06717698Phase 2Recruiting
A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease
Semaglutide
- NCT06716307Phase 1Completed
A Research Study to Compare Blood Levels of Cagrilintide and Semaglutide After Single Doses of Different Versions of Injectable CagriSema in Adults With Overweight or Obesity
Semaglutide
- NCT06821100Phase 1Recruiting
Thymalfasin (Thymosin Alpha 1; Ta1) as an Enhancer of Vaccine Response Among Older Adults Receiving Booster Doses of COVID-19 Vaccine
Thymosin-Alpha-1
- NCT06387199Phase 2/Phase 3Recruiting
Alleviating Carbohydrate Counting for Patients with Type-1 Diabetes Using a Closed Loop System with Weekly Subcutaneous Semaglutide
Semaglutide
- NCT06716216Phase 3Recruiting
A Study of BGM0504 in Participants with Type 2 Diabetes
Semaglutide
- NCT06517212Phase 2Recruiting
Tirzepatide Weight Loss for MRD+ Early Breast Cancer
Tirzepatide
- NCT06523530Phase 4Recruiting
Effect of a GnRH Analog on Hepatic Steatosis
Gonadorelin
- NCT07370922Phase 2Completed
Glucagon-Like Peptide 1 Receptor Agonist in Diabetes Mellitus Management in Children and Adolescents With Transfusion-Dependent Thalassemia
Dulaglutide
- NCT06191848Phase 4Recruiting
Subcutaneous Tirzepatide Once-weekly in Patients With Obesity and Knee Osteoarthritis (STOP KNEE-OA)
Tirzepatide
- NCT07018544N/AEnrolling By Invitation
A Multicentre, Prospective, Single-arm, Non-interventional Regulatory Post-marketing Surveillance (rPMS) Study to Investigate the Safety and Effectiveness of Wegovy® (Semaglutide) in Patients With Obesity and Patients With Overweight in Routine Clinical Practice in Korea
Semaglutide
- NCT06361238Phase 3Recruiting
Liraglutide in Preventing Delirium in Diabetic Elderly After Cardiac Surgery
Liraglutide
- NCT06672939Phase 3Recruiting
A Study of Orforglipron (LY3502970) in Adolescent Participants With Obesity, or Overweight With Related Comorbidities
Orforglipron
- NCT06672549Phase 3Recruiting
A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
Orforglipron
- NCT06761703N/ACompleted
A Study to Determine the Feasibility of Online Recruitment of People Using an Anti-Obesity Medication for Weight Loss
Tirzepatide
- NCT06246799Phase 3Recruiting
Comparative Effectiveness of Two Initial Combination Therapies in Patients With Recent Onset Diabetes
Tirzepatide
- NCT06632457Phase 3Recruiting
LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis
Survodutide
- NCT06534411Phase 3Active Not Recruiting
A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin, SGLT2 Inhibitor or Both
Tirzepatide
- NCT06662383Phase 3Active Not Recruiting
A Study of Retatrutide (LY3437943) Compared to Tirzepatide (LY3298176) in Adults Who Have Obesity
Retatrutide
- NCT06779929N/ACompleted
Comparative Study of Tirzepatide Versus Dulaglutide (SURPASS CVOT) or Semaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes
Tirzepatide
- NCT06467604N/AActive Not Recruiting
CRAVE Study: Comparing Craving Responses and Diet Quality of GLP1 Receptor Agonist Users
Tirzepatide
- NCT06616961Phase 3Not Yet Recruiting
Efficacy and Safety of Semaglutide for Weight Loss in Overweight or Obese Adults in Bangladesh With or Without Type 2 Diabetes Mellitus
Semaglutide
- NCT07092605EARLY_Phase 1Enrolling By Invitation
Effectiveness of Microdosed GLP-1 in Improving Health, Quality of Life, and Longevity Measures
Semaglutide
- NCT06649344Phase 3Active Not Recruiting
A Study of HRS9531 Versus Semaglutide Once Weekly as Add-on Therapy to Metformin Monotherapy or in Combination With SGLT2 Inhibitors in Participants With Type 2 Diabetes
Semaglutide
- NCT06518837Phase 2Recruiting
Tirzepatide for Weight Loss Intervention in Early-Stage Hormone Receptor Positive/HER2 Negative Breast Cancer
Tirzepatide
- NCT06162715Phase 2/Phase 3Enrolling By Invitation
GLP-1 Receptor Agonists Post-Bariatric Surgery (GRABS) Pilot Trial
Tirzepatide
- NCT06633783Phase 3Not Yet Recruiting
A Phase III Study Comparing the Weight Loss Effects of Semaglutide Injection and Wegovy®
Semaglutide
- NCT06659679N/ACompleted
Emulating the PIONEER6 Diabetes Trial Using Healthcare Claims
Semaglutide
- NCT06659744N/ACompleted
Emulation of the SUSTAIN6 Diabetes Trial Using Healthcare Claims
Semaglutide
- NCT06659718N/ACompleted
Emulation of the SOUL Diabetes Trial in Healthcare Claims
Semaglutide
- NCT07553988Phase 2Active Not Recruiting
A Comparative Dose-finding Study of RS-113 in Patients With Metastatic Castration-resistant Prostate Cancer
Gonadorelin
- NCT06649045Phase 3Active Not Recruiting
A Master Protocol for Orforglipron in Participants With Obstructive Sleep Apnea and Obesity or Overweight
Orforglipron